References
- Ferlay J , SoerjomatarmI, DikshitRet al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer136(5), E359–E386 (2015).
- Fagunwa IO , LoughreyMB, ColemanHG. Alcohol, smoking and the risk of premalignant and malignant colorectal neoplasms. Best Pract. Res. Clin. Gastroenterol.31(5), 561–568 (2017).
- Boada LD , Henríquez-HernándezLA, LuzardoOP. The impact of red and processed meat consumption on cancer and other health outcomes: epidemiological evidences. Food Chem. Toxicol.92, 236–244 (2016).
- Brevik A , JoshiAD, CorralR, Onland-MoretNCet al. Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat. Cancer Epi. Prev. Biomarkers19(12), 3167–3173 (2010).
- de Voer RM , van KesselAG, WerenRDet al. Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer. Gastroenterology145(3), 544–547 (2013).
- Kambara T , SimmsLA, WhitehallVet al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut53(8), 1137–1144 (2004).
- Imai Y , YamagishiH, FukudaKet al. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma. World J. Gastroenterol.19(25), 3957 (2013).
- Boltin D , PeretsTT, VilkinAet al. Mucin function in inflammatory bowel disease: an update. J. Clin. Gastroenterol.47(2), 106–111 (2013).
- Bhatia R , GautamSK, CannonAet al. Cancer-associated mucins: role in immune modulation and metastasis. Cancer Metast. Rev.38(1–2), 223–236 (2019).
- Shanmugam C , JhalaNC, KatkooriVRet al. Prognostic value of mucin 4 expression in colorectal adenocarcinomas. Cancer116(15), 3577–3586 (2010).
- Soliman BG , KaragkounisG, ChurchJMet al. Mucinous histology signifies poor oncologic outcome in young patients with colorectal cancer. Dis. Colon Rectum61(5), 547–553 (2018).
- Ham SY , KwonT, BakYet al. Mucin 1-mediated chemo-resistance in lung cancer cells. Oocogenesis5(1), e185 (2016).
- Takahashi H , JinC, RajabiHet al. MUC1-C activates the TAK1 inflammatory pathway in colon cancer. Oncogene34(40), 5187 (2015).
- Gupta B , DasP, GhoshSet al. Identification of high-risk aberrant crypt foci and mucin-depleted foci in the human colon with study of colon cancer stem cell markers. Clin. Colorectal Cancer16(3), 204–213 (2017).
- Lahdaoui F , MessagerM, VincentAet al. Depletion of MUC5B mucin in gastrointestinal cancer cells alters their tumorigenic properties: implication of the Wnt/β-catenin pathway. Biochem. J.474(22), 3733–3746 (2017).
- Thériault C , PinardM, ComamalaMet al. MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis. Gynecol. Oncol.121(3), 434–443 (2011).
- Sanchez-Vega F , MinaM, ArmeniaJet al. Oncogenic signaling pathways in the cancer genome atlas. Cell73(2), 321–337 (2018).
- Ritchie ME , PhipsonB, WuDet al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res.43(7), e47 (2015).
- Ha G , ShahS. Distinguishing somatic and germline copy number events in cancer patient DNA hybridized to whole-genome SNP genotyping arrays. Methods Mol. Biol.973, 355–372 (2013).
- Hochberg Y , BenjaminiY. More powerful procedures for multiple significance testing. Stat. Med.9(7), 811–818 (1990).
- Hinoue T , WeisenbergerDJ, LangeCPet al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res.22(2), 271–282 (2012).
- Langfelder P , HorvathS. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics9(1), 559 (2008).
- Zhang B , HorvathS. A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol.4(1), 1–43 (2005).
- Johansson ME , HanssonGC. Immunological aspects of intestinal mucus and mucins. Nat. Rev. Immunol.16(10), 639 (2016).
- Sheng YH , LourieR, LindénSKet al. The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis. Gut60(12), 1661–1670 (2011).
- Gupta BK , MaherDM, EbelingMCet al. Functions and regulation of MUC13 mucin in colon cancer cells. J. Gastroenterol.49(10), 1378–1391 (2014).
- van der Sluis M , de KoningBA, de BruijnACet al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology131(1), 117–129 (2006).
- Betge J , SchneiderNI, HarbaumLet al. MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. Virchows Arch.469(3), 255–265 (2016).
- Hattrup CL , GendlerSJ. Structure and function of the cell surface (tethered) mucins. Annu. Rev. Physiol.70, 431–457 (2008).
- Jonckheere N , Van SeuningenI. Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas. J. Transl. Med.16(1), 259 (2018).
- Haridas D , ChakrabortyS, PonnusamyMPet al. Pathobiological implications of MUC16 expression in pancreatic cancer. PLoS ONE6(10), e26839 (2011).
- Li X , PascheB, ZhangWet al. Association of MUC16 mutation with tumor mutation load and outcomes in patients with gastric cancer. JAMA Oncol.4(12), 1691–1698 (2018).
- Albrecht H , CarrawayIII KL. MUC1 and MUC4: switching the emphasis from large to small. Cancer Biother. Radiopharm.26(3), 61–271 (2011).
- Shanmugam C , JhalaNC, KatkooriVRet al. Prognostic value of mucin 4 expression in colorectal adenocarcinomas. Cancer116(15), 3577–3586 (2010).
- Wang W , ChenJ, ZhaoFet al. MiR-150-5p suppresses colorectal cancer cell migration and invasion through targeting MUC4. Asian Pac. J. Cancer Prev.15(15), 6269–6273 (2014).
- Peng QL , RenJ, YanXMet al. The g. 243A> G mutation in intron 17 of MUC4 is significantly associated with susceptibility/resistance to ETEC F4ab/ac infection in pigs. Anim. Genet.38(4), 397–400 (2007).
- Okudaira K , KakarS, CunLet al. MUC2 gene promoter methylation in mucinous and non-mucinous colorectal cancer tissues. Int. J. Oncol.36(4), 765–775 (2010).
- Tang J , ZhangL, SheXet al. Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo. Cancer Invest.30(5), 380–389 (2012).
- McManus S , ChababiW, ArsenaultDet al. Dissecting oncogenic RTK pathways in colorectal cancer initiation and progression. Methods Mol. Biol.1765, 27–42 (2018).
- Masliah-Planchon J , GarinetS, PasmantE. RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action. Oncotarget7(25), 38892 (2016).
- Dubois F , LeroyC, SimonVet al. YES oncogenic activity is specified by its SH4 domain and regulates RAS/MAPK signaling in colon carcinoma cells. Am. J. Cancer Res.5(6), 1972 (2015).
- Jiang H , WangY, AiMet al. Long noncoding RNA CRNDE stabilized by hnRNPUL2 accelerates cell proliferation and migration in colorectal carcinoma via activating Ras/MAPK signaling pathways. Cell Death Dis.8(6), e2862 (2017).
- Yokoyama S , HigashiM, TsutsumidaHet al. TET1-mediated DNA hypomethylation regulates the expression of MUC4 in lung cancer. Genes Cancer8(3–4), 517 (2017).
- Cho JS , ParkMH, LeeJSet al. Reduced MUC4 expression is a late event in breast carcinogenesis and is correlated with increased infiltration of immune cells as well as promoter hypermethylation in invasive breast carcinoma. Appl. Immunohisto. Mol. Morphol.23(1), 44–53 (2015).